AI Article Synopsis

  • A study investigated the relationship between anxiety, obesity, and sex hormones in a cohort of 3,124 adult women, focusing on both premenopausal and postmenopausal groups.
  • Results indicated that there were no significant differences in anxiety levels between obese and normal-weight premenopausal women, and both conditions were linked to elevated testosterone levels.
  • The findings revealed opposing effects of anxiety and obesity on estradiol levels in premenopausal women, but ultimately suggested that sex hormone changes related to obesity do not significantly impact anxiety symptoms.

Article Abstract

Several studies have shown a positive association between anxiety and obesity, particularly in women. We aimed to study whether sex hormone alterations related to obesity might play a role in this association. Data for this study were obtained from a population-based cohort study (the LIFE-Adult-Study). A total of 3,124 adult women (970 premenopausal and 2,154 postmenopausal) were included into the analyses. The anxiety symptomatology was assessed using the GAD-7 questionnaire (cut-off ≥ 10 points). Sex hormones were measured from fasting serum samples. We did not find significant differences in anxiety prevalence in premenopausal obese women compared with normal-weight controls (4.8% vs. 5.5%). Both obesity and anxiety symptomatology were separately associated with the same sex hormone alteration in premenopausal women: higher total testosterone level (0.97 ± 0.50 in obese vs. 0.86 ± 0.49 nmol/L in normal-weight women, = 0.026 and 1.04 ± 0.59 in women with vs. 0.88 ± 0.49 nmol/L in women without anxiety symptomatology, = 0.023). However, women with anxiety symptomatology had non-significantly higher estradiol levels than women without anxiety symptomatology (548.0 ± 507.6 vs. 426.2 ± 474.0 pmol/L), whereas obesity was associated with lower estradiol levels compared with those in normal-weight group (332.7 ± 386.5 vs. 470.8 ± 616.0 pmol/L). Women with anxiety symptomatology had also significantly higher testosterone and estradiol composition ( = 0.006). No associations of sex hormone levels and BMI with anxiety symptomatology in postmenopausal women were found. Although both obesity and anxiety symptomatology were separately associated with higher testosterone level, there was an opposite impact of anxiety and obesity on estradiol levels in premenopausal women. We did not find an evidence that the sex hormone alterations related to obesity are playing a significant role in anxiety symptomatology in premenopausal women. This could be the explanation why we did not find an association between obesity and anxiety. In postmenopausal women, other mechanisms seem to work than in the premenopausal group.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620895PMC
http://dx.doi.org/10.3389/fpsyt.2019.00479DOI Listing

Publication Analysis

Top Keywords

anxiety symptomatology
36
sex hormone
16
women anxiety
16
women
15
anxiety
13
obesity anxiety
12
premenopausal women
12
estradiol levels
12
symptomatology
9
sex hormones
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!